Caiji Lin

KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data

Shu-Lin Liu, Hongxia Bao, Songling Zhu, 2021, BMC Cancer.

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma

M. Köbel, E. Mastriani, L. Kelemen, 2020, Frontiers in Oncology.

The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas.

Min Liu, R. Johnston, Shu-Lin Liu, 2020, Current pharmaceutical design.

Thrombospondin-1 as a Potential Therapeutic Target: Multiple Roles in Cancers.

Shu-Lin Liu, Z. Zeng, Huidi Liu, 2020, Current pharmaceutical design.

Suppressive activities of mangiferin on human epithelial ovarian cancer.

Shu-Lin Liu, Siwen Wang, Yiting Liu, 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota.

Yufan Zhao, Hang Chen, Hao Yang, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Trabectedin in Cancers: Mechanisms and Clinical Applications.

Shu-Lin Liu, Yongwei Shi, Yufan Zhao, 2022, Current pharmaceutical design.

Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer

Shu-Lin Liu, Yongwei Shi, Yuanyuan Zhang, 2023, Journal of Cancer.

Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1

Qing Li, Shu-Lin Liu, Pathum Kossinna, 2023, Phytotherapy research : PTR.